These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6230344)

  • 1. The pharmacokinetics and tissue penetration of norfloxacin.
    Adhami ZN; Wise R; Weston D; Crump B
    J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
    Wise R; Lockley R; Webberly M; Adhami ZN
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and tissue penetration of ofloxacin.
    Lockley MR; Wise R; Dent J
    J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
    Wise R; Kirkpatrick B; Ashby J; Griggs DJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
    Wise R; Mortiboy D; Child J; Andrews JM
    Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin disposition after sequentially increasing oral doses.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    Antimicrob Agents Chemother; 1983 Feb; 23(2):284-8. PubMed ID: 6220672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin--a review of pharmacology and tissue penetration.
    Wise R
    J Antimicrob Chemother; 1984 May; 13 Suppl B():59-64. PubMed ID: 6234277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tissue penetration of orally administered pefloxacin.
    Webberley JM; Andrews JM; Ashby JP; McLeod A; Wise R
    Eur J Clin Microbiol; 1987 Oct; 6(5):521-4. PubMed ID: 3481335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.
    Eandi M; Viano I; Di Nola F; Leone L; Genazzani E
    Eur J Clin Microbiol; 1983 Jun; 2(3):253-9. PubMed ID: 6224683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
    Nakamura S; Kurobe N; Kashimoto S; Ohue T; Takase Y; Shimizu M
    Antimicrob Agents Chemother; 1983 Jul; 24(1):54-60. PubMed ID: 6226241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of norfloxacin in renal failure.
    Fillastre JP; Hannedouche T; Leroy A; Humbert G
    J Antimicrob Chemother; 1984 Oct; 14(4):439. PubMed ID: 6238930
    [No Abstract]   [Full Text] [Related]  

  • 12. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue penetration of enoxacin.
    Wise R; Lockley R; Dent J; Webberly M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.
    Wise R; Donovan IA; McNulty CA; Waldron R; Andrews JM
    J Hosp Infect; 1986 Mar; 7 Suppl A():47-55. PubMed ID: 2871097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA; Nye K; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.
    Hughes PJ; Webb DB; Asscher AW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():55-7. PubMed ID: 6234276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.
    Barre J; Houin G; Tillement JP
    J Pharm Sci; 1984 Oct; 73(10):1379-82. PubMed ID: 6594505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Crump B; Wise R; Dent J
    Antimicrob Agents Chemother; 1983 Nov; 24(5):784-6. PubMed ID: 6660852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and tissue penetration of teicoplanin.
    McNulty CA; Garden GM; Wise R; Andrews JM
    J Antimicrob Chemother; 1985 Dec; 16(6):743-9. PubMed ID: 2936707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.